HuangL., JansenL., BalavarcaY.Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations.Gut2017; pii: gutjnl-2017-314828. doi: 10.1136/gutjnl-2017-314828. [Epub ahead of print]
2.
LygidakisN.J., SpentzourisN., TheodoracopoulosM.Pancreatic resection for pancreatic carcinoma combined with neo- and adjuvant locoregional targeting immuno-chemotherapy—a prospective randomized study.Hepato-Gastroenterology1998; 45: 396–403.
3.
GolcherH., BrunnerT.B., WitzigmannH.Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospective randomized phase II trial.Strahlenther Onkol2015; 191: 7–16.
4.
CasadeiR., Di MarcoM., RicciC.Neoadjuvant chemoradiotherapy and surgery versus surgery alone in resectable pancreatic cancer: a single-center prospective, randomized, controlled trial which failed to achieve accrual targets.J Gastrointest Surg2015; 19: 1802–12.
